OREANDA-NEWS. December 02, 2015.  Allied World Assurance Company Holdings, AG (NYSE: AWH) today announced that Allied World North America, through a “Best in Class” relationship with Emerge Diagnostics, LLC (Emerge), will make Emerge’s Electrodiagnostic Functional Assessment - Soft Tissue Management (EFA-STM) Program available to Allied World’s Defense Base Act policyholders.

With soft tissue injuries as a leading driver of Defense Base Act claims and costs, Emerge’s EFA-STM Program is a bookend solution that provides employers with a non-discriminatory approach to determine if a work-related injury occurred within the course and scope of employment. After performing a baseline test, Emerge stores the unread data until a work-related injury is reported, in which case a post-incident test will be conducted and compared to the results of the baseline test. This comparison determines the nature, extent and age of the soft tissue injury and whether it relates to the reported incident. This diagnostic tool provides improved claims handling transparency, increased accuracy during diagnosis, enhanced patient care and rehabilitation. The EFA-STM program is portable for use overseas, convenient for medical personnel to administer and complies with Federal mandates.

Karen Marotta, Vice President at Allied World, commented, “We are extremely pleased to work with Emerge to bring our insureds this exciting technology. This will reduce lost productivity due to injuries of soft tissue claims, while improving diagnosis and treatment effectiveness.”

MaryRose Reaston, PhD, chief science officer and founder of Emerge Diagnostics, also commented, “Our EFA-STM program is a powerful tool in easing the strain and cost of soft tissue injury claims and creating better patient care and better outcomes for injured employees. Through this agreement, this unique and enhanced program will enable us to further expand the use of our technology outside of the U.S. and to new sectors of business.”

About Allied World

Allied World Assurance Company Holdings, AG, through its subsidiaries and brand known as Allied World, is a global provider of innovative property, casualty and specialty insurance and reinsurance solutions. Allied World offers superior client service through a global network of offices and branches. All of Allied World's rated insurance and reinsurance subsidiaries are rated A by A.M. Best Company, A by Standard & Poor's, and A2 by Moody's, and our Lloyd's Syndicate 2232 is rated A+ by Standard & Poor's and AA- by Fitch.

Please visit the following for further information on Allied World: Web: www.awac.com | Facebook: www.facebook.com/alliedworld | LinkedIn: http://www.linkedin.com/company/Allied-World.

About Emerge Diagnostics

Headquartered in Carlsbad, Emerge Diagnostics is delivering a new way to determine the location and age of soft tissue injuries. The Company's technology provides the most comprehensive and actionable pre- and post-injury test to determine whether an injury actually arose in the workplace. Emerge Diagnostics works with employers, occupational health clinics and insurance carriers/TPAs to create better patient outcomes and reduced costs. Emerge is leading the way with technological development and ongoing innovation to improve workplace injury outcomes and return-to-work times. For more information, visit emergedx.com.

Cautionary Statement Regarding Forward-Looking Statements

Any forward-looking statements made in this press release reflect our current views with respect to future events and financial performance and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements involve risks and uncertainties, which may cause actual results to differ materially from those set forth in these statements. For example, our forward-looking statements could be affected by pricing and policy term trends; increased competition; the adequacy of our loss reserves; negative rating agency actions; greater frequency or severity of unpredictable catastrophic events; the impact of acts of terrorism and acts of war; the company or its subsidiaries becoming subject to significant income taxes in the United States or elsewhere; changes in regulations or tax laws; changes in the availability, cost or quality of reinsurance or retrocessional coverage; adverse general economic conditions; and judicial, legislative, political and other governmental developments, as well as management's response to these factors, and other factors identified in our filings with the U.S. Securities and Exchange Commission. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date on which they are made. We are under no obligation (and expressly disclaim any such obligation) to update or revise any forward-looking statement that may be made from time to time, whether as a result of new information, future developments or otherwise.